Tianbao Songyuan

Guangzhou Tianbao Songyuan Biotechnology Development Co., Ltd. was established in 2007, with its headquarters in Guangzhou. The company is dedicated to the research, development, production, and sales of point-of-care testing (POCT) products (including reagents and instruments) in the in vitro diagnostics sector of biomedicine, and is a leading POCT solution provider both at home and abroad. Since its inception over the past 10 years, the company has independently developed a globally advanced biofluorescent labeling marker, successfully applied it in the medical testing field, and filed 55 invention patents with 25 granted. With its continuously innovative biofluorescent technology platform and proprietary intellectual property protection, Tianbao Songyuan holds a leading position in the POCT field. The Baolian Lantern TM series of biofluorescent immunoassay systems is the first POCT immunoassay analyzer both domestically and internationally to employ the fluorescent immunoassay endpoint method, and is the world's first POCT system to use biofluorescent markers for fully quantitative detection. The product performance ranks among the top tier globally in the POCT sector, comparable to large-scale automated platforms of internationally renowned brands, and offers advantages such as rapidity, convenience, accuracy, and a comprehensive product line. As a pioneer in the POCT field, Tianbao Songyuan focuses on providing technologically advanced solutions for every aspect of POCT. Its comprehensive solutions encompass immunoassays for infectious inflammation, cardiovascular, and renal function testing, boasting the most complete product line in the industry both domestically and internationally. The company's infectious inflammation series includes CRP, PCT, etc., featuring whole blood testing, full quantification, and high efficiency and speed; the cardiovascular series includes NT-proBNP, h-FABP, cTnI, MYO, CK-MB, D-Dimer, MPO, Lp-PLA2, cTnI/h-FABP/MYO triple card, and cTnI/CK-MB/MYO triple card, etc., offering advantages such as the most comprehensive panel, rapid accuracy, and high repeatability, providing comprehensive and systematic solutions for cardiovascular disease diagnosis, monitoring, and prognosis; renal function testing primarily includes β2-MG, mALB, and NGAL, and is the only one in the renal function testing field capable of providing rapid, fully quantitative POCT products. Tianbao Songyuan adheres to the principle of leading the future with lean technology and seeks long-term development. The company's upcoming product lines include tumor marker detection, viral infection detection, drug concentration monitoring, and Alzheimer's disease detection series. The elite team and excellent human resources are the core strength of Tianbao Songyuan. We respect the development needs of our employees and seek mutual development between the company and its staff. Tianbao Songyuan embodies a motivating force that can only be truly appreciated after you join our team. Our employees love life, are passionate about the healthcare cause, and contribute enthusiastically to the lives of others. We welcome aspiring individuals to join Tianbao and grow together with Tianbao!